Mark A. Goldsmith, See Remarks at Revolution Medicines, Inc. (RVMD), sold 120,000 shares at $150.09 ($18.0M) on 2026-04-15, disclosed to the SEC on 2026-04-17.
Scheduled sale ($18.0M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RVMD | SELL | 2026-06-18 | $1.6M | — | Filing → |
| RVMD | SELL | 2026-03-19 | $2.6M | — | Filing → |
| RVMD | SELL | 2026-03-03 | $7.2M | — | Filing → |